Page last updated: 2024-10-27

fluorouracil and Empyema

fluorouracil has been researched along with Empyema in 2 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Empyema: Presence of pus in a hollow organ or body cavity.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atanaskova Mesinkovska, N1
Conic, RZ1
Kiracofe, EA1
Vidimos, AT1
Pirogov, AI1
Maksimov, IA1
Os'makov, NA1

Other Studies

2 other studies available for fluorouracil and Empyema

ArticleYear
Treatment of invasive squamous cell carcinomas in an open Clagett window.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2015, Volume: 41, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Debride

2015
[Postoperative bronchopleural complications in the combined treatment of lung cancer].
    Voprosy onkologii, 1974, Volume: 20, Issue:6

    Topics: Adult; Antineoplastic Agents; Bronchial Fistula; Cyclophosphamide; Dose-Response Relationship, Radia

1974